TRexBio’s platform, dubbed Deep Biology, helps identify and characterize novel targets by mapping human tissue Treg behavior to disease processes. As key regulators of the immune system, Tregs play important roles in tissue inflammation and mediation of tissue healing. Deep Biology has identified more than 20 novel tissue-focused targets so far. The platform has three pillars: A high-resolution map or “Atlas” of tissue Treg pathways in health and disease, computational tools, and a suite of functional assays in human primary Tregs . . .
See More on the Edge
Continue reading this article and more
with a GEN Edge subscription
The post Jurassic Ambitions: TRexBio Targets Tregs with Janssen Collaboration appeared first on GEN – Genetic Engineering and Biotechnology News.